Screening

Created:   2/17/2015
Contains:  24 items

1 2 3 4 5

Low Serum Levels of MicroRNA-19 Are Associated with a Stricturing Crohn's Disease Phenotype

Lewis, Amy; Mehta, Shameer; Hanna, Luke N.; More

Inflammatory Bowel Diseases. 21(8):1926-1934, August 2015.

Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: An Economic Evaluation

Negrón, María E.; Kaplan, Gilaad G.; Barkema, Herman W.; More

Inflammatory Bowel Diseases. 20(11):2046-2055, November 2014.

Performance of Interferon-gamma Release Assay for Tuberculosis Screening in Inflammatory Bowel Disease Patients

Wong, Sunny H.; Ip, Margaret; Tang, Whitney; More

Inflammatory Bowel Diseases. 20(11):2067-2072, November 2014.

The Clinical Utility of Health-Related Quality of Life Screening in a Pediatric Inflammatory Bowel Disease Clinic

Ryan, Jamie L.; Mellon, Michael W.; Junger, Katherine W. F.; More

Inflammatory Bowel Diseases. 19(12):2666-2672, November 2013.

The Utility of Screening for Asymptomatic Lower Extremity Deep Venous Thrombosis during Inflammatory Bowel Disease Flares: A Pilot Study

Nguyen, Geoffrey C.; Wu, Harry; Gulamhusein, Aliya; More

Inflammatory Bowel Diseases. 19(5):1053-1058, April 2013.

Factors impacting the results of interferon‐γ release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases

Papay, Pavol; Eser, Alexander; Winkler, Stefan; More

Inflammatory Bowel Diseases. 17(1):84-90, January 2011.

1 2 3 4 5